Current perspectives on the immunopathogenesis of systemic sclerosis Current perspectives on the immunopathogenesis of systemic sclerosis( Fuschiotti, 2015)
Iloprost treatment in patients with Raynauds Phenomenon secondary to systemic sclerosis Iloprost treatment in patients with Raynaud’s phenomenon secondary to systemic sclerosis and the quality of life: a new therapeutic protocol ( Milio et al, 2006)
